Myda Advisors LLC 9 Meters Biopharma, Inc. Transaction History

Myda Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$1.04 - $1.5 $41,600 - $60,000	-40,000 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$0.84 - $2.16 $268,800 - $691,200	-320,000 Reduced 88.89%	40,000 $47,000
Q4 2020 Feb 12, 2021	BUY	$0.65 - $1.11 $234,000 - $399,600	360,000 New	360,000 $309,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Myda Advisors LLC with notifications on news.